United States Healthcare Equipment & Supplies

HTG Molecular Diagnostics Inc (HTGM)

Track

Track

Ticker: HTGM Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for HTG Molecular Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Barat Stephen Senior VP of Therapeutics Officer
Transaction date
Sale
Price
433.16
Quantity 17,218 +27.9%
Value US$535,899
JOHNSON TIM B Executive Chairman Executive Director
Transaction date
Planned sale
Price
28.37
Quantity 85,925 -24.1%
Value US$3,112,150
McMeans Shaun D VP, Finance & Admin. & CFO
Transaction date
Planned sale
Price
380.89
Quantity 98,011 +8.0%
Value US$64,132
McMeans Shaun D VP, Finance & Admin. & CFO
Transaction date
Planned sale
Price
2.26
Quantity 945 -2.1%
Value US$2,136
McMeans Shaun D VP, Finance & Admin. & CFO
Transaction date
Planned sale
Price
2.27
Quantity 946 -2.1%
Value US$2,148
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
1.75
Quantity 720,214 -100.0%
Value US$1,260,591
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
1.91
Quantity 382,437 -34.7%
Value US$729,919
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
2.02
Quantity 47,162 -4.1%
Value US$95,475
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
2.01
Quantity 12,641 -1.0%
Value US$25,412
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
2.02
Quantity 12,845 -1.0%
Value US$25,976
Novo Holdings A/S Large shareholder
Transaction date
Sale
Price
2.10
Quantity 55,100 -4.3%
Value US$115,600
GLAXOSMITHKLINE PLC
Transaction date
Sale
Price
10.15
Quantity 300,000 -27.5%
Value US$3,045,180
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.92
Quantity 183 -1.0%
Value US$535
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.92
Quantity 538 -1.0%
Value US$1,573
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.92
Quantity 175 -0.9%
Value US$512
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.92
Quantity 87 -0.3%
Value US$254
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.89
Quantity 1,489 -7.8%
Value US$4,301
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.89
Quantity 4,376 -7.9%
Value US$12,641
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.89
Quantity 1,426 -6.6%
Value US$4,119
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.89
Quantity 709 -2.7%
Value US$2,048
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.19
Quantity 109 -0.6%
Value US$238
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.19
Quantity 109 -0.5%
Value US$238
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.19
Quantity 125 -0.2%
Value US$273
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.19
Quantity 113 -0.4%
Value US$247
Roche Patrick C. SVP Research & Development Officer
Transaction date
Planned sale
Price
2.19
Quantity 111 -0.6%
Value US$243
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.36
Quantity 4,215 -17.9%
Value US$9,928
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.36
Quantity 4,305 -16.6%
Value US$10,140
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.36
Quantity 8,154 -12.7%
Value US$19,206
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.36
Quantity 5,264 -16.9%
Value US$12,399
Roche Patrick C. SVP Research & Development Officer
Transaction date
Planned sale
Price
2.36
Quantity 4,520 -19.0%
Value US$10,646
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.49
Quantity 1,211 -4.9%
Value US$3,016
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.49
Quantity 1,237 -4.5%
Value US$3,081
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.49
Quantity 2,342 -3.5%
Value US$5,832
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.49
Quantity 1,512 -4.6%
Value US$3,765
Roche Patrick C. SVP Research & Development Officer
Transaction date
Planned sale
Price
2.49
Quantity 1,298 -5.2%
Value US$3,232
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Planned sale
Price
2.69
Quantity 3,325 -10.9%
Value US$8,933
JOHNSON TIM B President & CEO Executive Director
Transaction date
Planned sale
Price
2.69
Quantity 6,299 -8.7%
Value US$16,924
Lubniewski John L Chief Business Officer Officer
Transaction date
Planned sale
Price
2.69
Quantity 4,067 -11.1%
Value US$10,927
Roche Patrick C. SVP Research & Development Officer
Transaction date
Planned sale
Price
2.69
Quantity 3,491 -12.2%
Value US$9,379
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Planned sale
Price
2.69
Quantity 3,256 -11.6%
Value US$8,748
JOHNSON TIM B President & CEO Executive Director
Transaction date
Purchase
Price
5.34
Quantity 1,000 +9.3%
Value US$5,341
Gordon Debra A V.P. and Chief Legal Counsel Officer
Transaction date
Purchase
Price
5.16
Quantity 1,000 +280.9%
Value US$5,160
Roche Patrick C. SVP Research & Development Officer
Transaction date
Purchase
Price
5.75
Quantity 5,800 +828.6%
Value US$33,350
Roche Patrick C. SVP Research & Development Officer
Transaction date
Purchase
Price
5.83
Quantity 100 +16.7%
Value US$583
Roche Patrick C. SVP Research & Development Officer
Transaction date
Purchase
Price
5.84
Quantity 400 +200.0%
Value US$2,336
Roche Patrick C. SVP Research & Development Officer
Transaction date
Purchase
Price
5.83
Quantity 200 +inf%
Value US$1,166
JOHNSON TIM B President & CEO Executive Director
Transaction date
Purchase
Price
7.31
Quantity 300 +2.9%
Value US$2,193
JOHNSON TIM B President & CEO Executive Director
Transaction date
Purchase
Price
7.46
Quantity 300 +3.0%
Value US$2,238
JOHNSON TIM B President & CEO Executive Director
Transaction date
Purchase
Price
7.62
Quantity 2,000 +24.6%
Value US$15,240
JOHNSON TIM B President & CEO Executive Director
Transaction date
Purchase
Price
7.48
Quantity 2,400 +42.0%
Value US$17,952
McMeans Shaun D VP, Finance & Admin. & CFO Officer
Transaction date
Purchase
Price
7.50
Quantity 650 +22.9%
Value US$4,875
Lubniewski John L Chief Business Officer Officer
Transaction date
Purchase
Price
7.50
Quantity 14 +0.2%
Value US$105
Lubniewski John L Chief Business Officer Officer
Transaction date
Purchase
Price
7.67
Quantity 4,986 +139.6%
Value US$38,243
Fletcher Spaght Ventures II LP Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 102,445 +24.6%
Value US$1,434,230
Merck Capital Ventures LLC Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 167,343 +28.4%
Value US$2,342,802
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 365,106 +inf%
Value US$5,111,484
Novo A/S Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 365,106 +39.9%
Value US$5,111,484
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-09 2023-06-08 S Sale
Barat Stephen

Senior VP of Therapeutics

Officer
17,218 +27.9%
433.16
US$535,899 		17,218 +27.9% 433.16 US$535,899
2020-01-02 2019-12-26 PlS Planned sale
JOHNSON TIM B

Executive Chairman

Executive Director
85,925 -24.1%
28.37
US$3,112,150 		85,925 -24.1% 28.37 US$3,112,150
2017-12-01 2017-12-01 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
98,011 +8.0%
380.89
US$64,132 		98,011 +8.0% 380.89 US$64,132
2017-11-03 2017-11-01 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
945 -2.1%
2.26
US$2,136 		945 -2.1% 2.26 US$2,136
2017-10-18 2017-10-16 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO
946 -2.1%
2.27
US$2,148 		946 -2.1% 2.27 US$2,148
2017-08-25 2017-08-25 S Sale Novo Holdings A/S Large shareholder
720,214 -100.0%
1.75
US$1,260,591 		720,214 -100.0% 1.75 US$1,260,591
2017-08-25 2017-08-24 S Sale Novo Holdings A/S Large shareholder
382,437 -34.7%
1.91
US$729,919 		382,437 -34.7% 1.91 US$729,919
2017-08-25 2017-08-23 S Sale Novo Holdings A/S Large shareholder
47,162 -4.1%
2.02
US$95,475 		47,162 -4.1% 2.02 US$95,475
2017-08-22 2017-08-22 S Sale Novo Holdings A/S Large shareholder
12,641 -1.0%
2.01
US$25,412 		12,641 -1.0% 2.01 US$25,412
2017-08-22 2017-08-21 S Sale Novo Holdings A/S Large shareholder
12,845 -1.0%
2.02
US$25,976 		12,845 -1.0% 2.02 US$25,976
2017-08-22 2017-08-18 S Sale Novo Holdings A/S Large shareholder
55,100 -4.3%
2.10
US$115,600 		55,100 -4.3% 2.10 US$115,600
2017-03-29 2017-03-27 S Sale GLAXOSMITHKLINE PLC
300,000 -27.5%
10.15
US$3,045,180 		300,000 -27.5% 10.15 US$3,045,180
2016-04-05 2016-04-04 PlS Planned sale Gordon Debra A

V.P. and Chief Legal Counsel

Officer
183 -1.0%
2.92
US$535 		183 -1.0% 2.92 US$535
2016-04-05 2016-04-04 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
538 -1.0%
2.92
US$1,573 		538 -1.0% 2.92 US$1,573
2016-04-05 2016-04-04 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
175 -0.9%
2.92
US$512 		175 -0.9% 2.92 US$512
2016-04-05 2016-04-04 PlS Planned sale Lubniewski John L

Chief Business Officer

Officer
87 -0.3%
2.92
US$254 		87 -0.3% 2.92 US$254
2016-04-05 2016-04-01 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,489 -7.8%
2.89
US$4,301 		1,489 -7.8% 2.89 US$4,301
2016-04-05 2016-04-01 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
4,376 -7.9%
2.89
US$12,641 		4,376 -7.9% 2.89 US$12,641
2016-04-05 2016-04-01 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
1,426 -6.6%
2.89
US$4,119 		1,426 -6.6% 2.89 US$4,119
2016-04-05 2016-04-01 PlS Planned sale Lubniewski John L

Chief Business Officer

Officer
709 -2.7%
2.89
US$2,048 		709 -2.7% 2.89 US$2,048
2016-03-14 2016-03-14 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
109 -0.6%
2.19
US$238 		109 -0.6% 2.19 US$238
2016-03-14 2016-03-14 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
109 -0.5%
2.19
US$238 		109 -0.5% 2.19 US$238
2016-03-14 2016-03-14 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
125 -0.2%
2.19
US$273 		125 -0.2% 2.19 US$273
2016-03-14 2016-03-14 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
113 -0.4%
2.19
US$247 		113 -0.4% 2.19 US$247
2016-03-14 2016-03-14 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
111 -0.6%
2.19
US$243 		111 -0.6% 2.19 US$243
2016-03-14 2016-03-11 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
4,215 -17.9%
2.36
US$9,928 		4,215 -17.9% 2.36 US$9,928
2016-03-14 2016-03-11 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
4,305 -16.6%
2.36
US$10,140 		4,305 -16.6% 2.36 US$10,140
2016-03-14 2016-03-11 PlS Planned sale JOHNSON TIM B

President & CEO

Executive Director
8,154 -12.7%
2.36
US$19,206 		8,154 -12.7% 2.36 US$19,206
2016-03-14 2016-03-11 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
5,264 -16.9%
2.36
US$12,399 		5,264 -16.9% 2.36 US$12,399
2016-03-14 2016-03-11 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
4,520 -19.0%
2.36
US$10,646 		4,520 -19.0% 2.36 US$10,646
2016-03-14 2016-03-10 PlS Planned sale Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,211 -4.9%
2.49
US$3,016 		1,211 -4.9% 2.49 US$3,016
2016-03-14 2016-03-10 PlS Planned sale McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
1,237 -4.5%
2.49
US$3,081 		1,237 -4.5% 2.49 US$3,081
2016-03-14 2016-03-10 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
2,342 -3.5%
2.49
US$5,832 		2,342 -3.5% 2.49 US$5,832
2016-03-14 2016-03-10 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
1,512 -4.6%
2.49
US$3,765 		1,512 -4.6% 2.49 US$3,765
2016-03-14 2016-03-10 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
1,298 -5.2%
2.49
US$3,232 		1,298 -5.2% 2.49 US$3,232
2016-03-09 2016-03-09 PlS Planned sale
McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
3,325 -10.9%
2.69
US$8,933 		3,325 -10.9% 2.69 US$8,933
2016-03-09 2016-03-09 PlS Planned sale
JOHNSON TIM B

President & CEO

Executive Director
6,299 -8.7%
2.69
US$16,924 		6,299 -8.7% 2.69 US$16,924
2016-03-09 2016-03-09 PlS Planned sale
Lubniewski John L

Chief Business Officer

Officer
4,067 -11.1%
2.69
US$10,927 		4,067 -11.1% 2.69 US$10,927
2016-03-09 2016-03-09 PlS Planned sale
Roche Patrick C.

SVP Research & Development

Officer
3,491 -12.2%
2.69
US$9,379 		3,491 -12.2% 2.69 US$9,379
2016-03-09 2016-03-09 PlS Planned sale
Gordon Debra A

V.P. and Chief Legal Counsel

Officer
3,256 -11.6%
2.69
US$8,748 		3,256 -11.6% 2.69 US$8,748
2015-08-25 2015-08-24 B Purchase JOHNSON TIM B

President & CEO

Executive Director
1,000 +9.3%
5.34
US$5,341 		1,000 +9.3% 5.34 US$5,341
2015-08-24 2015-08-24 B Purchase Gordon Debra A

V.P. and Chief Legal Counsel

Officer
1,000 +280.9%
5.16
US$5,160 		1,000 +280.9% 5.16 US$5,160
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
5,800 +828.6%
5.75
US$33,350 		5,800 +828.6% 5.75 US$33,350
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
100 +16.7%
5.83
US$583 		100 +16.7% 5.83 US$583
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
400 +200.0%
5.84
US$2,336 		400 +200.0% 5.84 US$2,336
2015-08-19 2015-08-18 B Purchase Roche Patrick C.

SVP Research & Development

Officer
200 +inf%
5.83
US$1,166 		200 +inf% 5.83 US$1,166
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
300 +2.9%
7.31
US$2,193 		300 +2.9% 7.31 US$2,193
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
300 +3.0%
7.46
US$2,238 		300 +3.0% 7.46 US$2,238
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
2,000 +24.6%
7.62
US$15,240 		2,000 +24.6% 7.62 US$15,240
2015-08-13 2015-08-12 B Purchase JOHNSON TIM B

President & CEO

Executive Director
2,400 +42.0%
7.48
US$17,952 		2,400 +42.0% 7.48 US$17,952
2015-08-12 2015-08-12 B Purchase McMeans Shaun D

VP, Finance & Admin. & CFO

Officer
650 +22.9%
7.50
US$4,875 		650 +22.9% 7.50 US$4,875
2015-08-12 2015-08-11 B Purchase Lubniewski John L

Chief Business Officer

Officer
14 +0.2%
7.50
US$105 		14 +0.2% 7.50 US$105
2015-08-12 2015-08-11 B Purchase Lubniewski John L

Chief Business Officer

Officer
4,986 +139.6%
7.67
US$38,243 		4,986 +139.6% 7.67 US$38,243
2015-05-13 2015-05-11 B Purchase Fletcher Spaght Ventures II LP Large shareholder
102,445 +24.6%
14.00
US$1,434,230 		102,445 +24.6% 14.00 US$1,434,230
2015-05-13 2015-05-11 B Purchase Merck Capital Ventures LLC Large shareholder
167,343 +28.4%
14.00
US$2,342,802 		167,343 +28.4% 14.00 US$2,342,802
2015-05-13 2015-05-11 B Purchase GLAXOSMITHKLINE PLC Large shareholder
365,106 +inf%
14.00
US$5,111,484 		365,106 +inf% 14.00 US$5,111,484
2015-05-12 2015-05-11 B Purchase Novo A/S Large shareholder
365,106 +39.9%
14.00
US$5,111,484 		365,106 +39.9% 14.00 US$5,111,484
Explore more

More insider trading research around HTG Molecular Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America